INSIGHTS ON CLINICAL TRIAL DESIGN

• Breaking Barriers In Drug Development: Time, Trust And Putting Patients First

  Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.

• Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements

  In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).

• Challenges To Making Go/No-Go Decisions In Clinical Trials

  In drug development, a go/no-go decision can be a high-stakes trade-off between speed and certainty. Delve into the real-world operational and strategic hurdles to making those decisions.

• Cohort Configuration Feature Of An RTSM Platform

  Master trial agility by building and prioritizing cohorts in real time. Effortlessly manage dose levels and enrollment limits to keep your study on track, even as protocols evolve.

• From Protocol Design To Actual Patients In Studies

  4/22/2026

  Explore how clinical trial success increasingly depends on aligning recruitment strategies with protocol complexity through data-driven insights and tailored engagement approaches.

• A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity

  3/28/2025

  The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.

• Faster Starts, Stronger Finish: Operational Excellence In NSCLC

  5/22/2026

  In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.

• Use Data For Fit-For-Purpose Patient Recruitment Strategy

  10/29/2025

  Learn how a proactive, data-integrated approach can transform patient recruitment from a reactive hurdle into a built-in advantage — accelerating enrollment, improving representativeness, and setting studies up for success from day one.

• Patient Liaison Support In Rare Disease Trials

  2/11/2026

  Real stories from rare disease trials show how attentive communication, logistical coordination, and timely reimbursement reduce stress for participants while keeping long-term engagement.